Pancreatic mucinous cystic neoplasm

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

Pancreatic mucinous cystic neoplasm (MCN)

Pancreatic MCN is a cystic lesion in the pancreas. It is more common in women and typically occurs between ages 40 and 60. Most MCNs are benign, but they can progress to cancer. About 10% of MCNs are malignant. If the cyst is removed before it becomes invasive cancer, the prognosis is excellent. The extent of invasion is the most important factor for survival.

What it looks like under the microscope: mucin-producing columnar lining cells surrounded by ovarian-like stroma; calcification may occur. Features that raise concern for cancer include a multichambered cyst, mural nodules, papillary projections, p53 changes, and loss of ovarian-like stroma.

Diagnosis usually relies on imaging (CT or MRI). If results are unclear, endoscopic ultrasound with fine-needle aspiration (EUS-FNA) may be used. Analyzing cyst fluid helps distinguish mucinous from benign non-mucinous cysts, but it cannot rule out cancer or high-grade dysplasia.

Treatment: surgery is preferred when feasible. If the cyst appears benign and the person has no symptoms, careful monitoring with regular imaging may be reasonable. If the resection shows MCN without cancer, no further postoperative imaging is typically needed.

For those who cannot have surgery, EUS-guided therapy (such as alcohol lavage with paclitaxel injection) has been tried, but more research is needed. This approach seems more effective for smaller MCNs.

Notes: MCNs are more common in women. In a study of pancreatic cyst surgeries, about 23% were MCN, and malignancy occurred in about 10% of MCNs, with cancer more likely in older individuals.